https://fpwr2.tasdemo.co.uk/cool_timeline/co-funded-phase-1-study-of-diazoxide-choline-dccr/2020-10-20T21:44:00+01:00https://fpwr2.tasdemo.co.uk/cool_timeline/funded-screening-of-10000-molecules-in-search-of-drug-candidates-for-generic-therapy/2020-07-14T15:06:55+01:00https://fpwr2.tasdemo.co.uk/cool_timeline/launched-the-global-pws-registry/2020-07-14T15:07:20+01:00https://fpwr2.tasdemo.co.uk/cool_timeline/established-the-pws-clinical-trials-consortium/2020-07-14T15:07:42+01:00https://fpwr2.tasdemo.co.uk/cool_timeline/awarded-drs-chamberlain-and-carmichael-pilot-funding-in-pws-genetics-research/2020-11-23T21:43:20+00:00https://fpwr2.tasdemo.co.uk/cool_timeline/more-than-2000-patients-are-enrolled-in-the-global-pws-registry/2020-07-14T15:09:36+01:00https://fpwr2.tasdemo.co.uk/cool_timeline/phase-3-dccr-trial-top-line-results/2020-10-20T16:54:03+01:00https://fpwr2.tasdemo.co.uk/cool_timeline/carbetocin/2020-10-26T22:31:36+00:00https://fpwr2.tasdemo.co.uk/cool_timeline/dccr-extension-results/2021-10-01T14:09:05+01:00https://fpwr2.tasdemo.co.uk/cool_timeline/2022-funding-project-genetic-determinants-of-behavioural-physical-and-physiological-characteristics-of-pws/2024-03-15T15:04:32+00:00https://fpwr2.tasdemo.co.uk/cool_timeline/dccr-reports-positive-results/2024-03-15T15:31:03+00:00https://fpwr2.tasdemo.co.uk/cool_timeline/pitolisant-earns-fda-orphan-drug-status-ahead-of-phase-3-trial/2024-03-15T15:13:52+00:00https://fpwr2.tasdemo.co.uk/cool_timeline/six-drug-trials-at-phase-two-or-phase-three/2024-03-15T15:22:41+00:00https://fpwr2.tasdemo.co.uk/cool_timeline/exciting-new-treatment-may-reduce-disruptive-behaviors-in-pws/2024-03-15T15:26:10+00:00https://fpwr2.tasdemo.co.uk/cool_timeline/dccr-approval-in-the-usa/2025-03-27T20:07:38+00:00